FINEME / COMPANY INTELLIGENCE

Company Intelligence

See what changed in published company financial reports, follow the businesses you care about, and compare a small sample from the same industry. Figures are historical—not share prices or investment recommendations.

My World ↗Compare companies ↗

01 / MY COMPANY WATCHLIST

Your followed companies

Read the latest financial periods and filing-list dates saved for companies you follow in My World.

Manage in My World →

Loading followed companies…

Followed companies and last-check comparisons are kept in this browser only. A changed badge means stored information changed since this browser last checked, not that a new filing occurred at that moment.

02 / FIND A BUSINESS

Browse the company directory

Search by name, ticker or CIK. Browse all matching listings, including companies without available analysis.

AAGILENT TECHNOLOGIES, INC.

Inspect →

AAAlcoa Corp

Inspect →

AAAUGoldman Sachs Physical Gold ETF

Inspect →

AACAres Acquisition Corp III

Inspect →

AACGATA Creativity Global

Inspect →

AACIArmada Acquisition Corp. III

Inspect →

AACOAbony Acquisition Corp. I

Inspect →

AACPApogee Acquisition Corp

Inspect →

AADXApplied Aerospace & Defense, Inc.

Inspect →

AAGHAmerica Great Health

Inspect →

AALAmerican Airlines Group Inc.

Inspect →

AAMEATLANTIC AMERICAN CORP

Inspect →

03 / FINANCIAL CHANGES

CVS HEALTH Corp CVS

Retail-Drug Stores and Proprietary Stores · SIC 5912

Full analysis →

Latest standalone quarter

Period ending 2026-09-30

Filed: 2026-11-04 · Retrieved: 2026-11-06

Compared with the same period of the prior year, ending 2025-09-30.

Revenue108,399.00

USD million

Change year over year: +5,528.00 · +5.4%

Net income2,172.00

USD million

Change year over year: +6,147.00

Operating cash flow4,724.00

USD million

Change year over year: +3,928.00

Total liabilities177,386.00

USD million

Change year over year: -4,831.00

Total assets258,075.00

USD million

Change year over year: +2,748.00

Liabilities / assets: 68.7% · Change: -2.6 percentage points

Open original filing ↗

Latest annual report

Period ending 2025-12-31

Filed: 2026-02-10 · Retrieved: 2026-11-06

Compared with the same period of the prior year, ending 2024-12-31.

Revenue402,067.00

USD million

Change year over year: +29,258.00 · +7.8%

Net income1,768.00

USD million

Change year over year: -2,846.00

Operating cash flow10,639.00

USD million

Change year over year: +1,532.00

Total liabilities178,156.00

USD million

Change year over year: +671.00

Total assets253,538.00

USD million

Change year over year: +323.00

Liabilities / assets: 70.3% · Change: +0.2 percentage points

Open original filing ↗

04 / INDUSTRY CONTEXT

Other companies with the same SIC classification

A small, non-ranked sample of available annual reports. Periods and business models may differ.

Company	Period ending	Revenue (USD million)	Net margin	Operating cash margin
PETS ↗	2026-03-31	179.02	-32.0%	-15.9%
GRDN ↗	2025-12-31	1,448.69	3.4%	6.9%
CANN ↗	2023-12-31	18.14	-39.0%	-6.2%

Same SIC does not prove businesses are direct competitors. Annual periods may differ; margins may not be meaningful for every industry. Missing data are not zero and this is not a stock ranking.

05 / RECENT FINANCIAL RECORDS

Recently filed reports in the imported dataset

These are the newest filing dates found in the locally available annual and quarterly financial records. Not a real-time SEC feed; late imports and amended filings may affect what appears.

Latest standalone quarter

INO ↗

INOVIO PHARMACEUTICALS, INC.

Filed: 2026-11-10
Period ending: 2026-09-30

Latest standalone quarter

PRPO ↗

Precipio, Inc.

Filed: 2026-11-10
Period ending: 2026-09-30

Latest standalone quarter

PETS ↗

PETMED EXPRESS INC

Filed: 2026-11-10
Period ending: 2026-09-30

Latest standalone quarter

SLAB ↗

SILICON LABORATORIES INC.

Filed: 2026-11-10
Period ending: 2026-10-03

Latest standalone quarter

EPM ↗

EVOLUTION PETROLEUM CORP

Filed: 2026-11-10
Period ending: 2026-09-30

Latest standalone quarter

PLX ↗

Protalix BioTherapeutics, Inc.

Filed: 2026-11-10
Period ending: 2026-09-30

Latest standalone quarter

WAT ↗

WATERS CORP /DE/

Filed: 2026-11-10
Period ending: 2026-10-03

Latest standalone quarter

FCCO ↗

FIRST COMMUNITY CORP /SC/

Filed: 2026-11-10
Period ending: 2026-09-30

Latest standalone quarter

EFOI ↗

ENERGY FOCUS, INC/DE

Filed: 2026-11-10
Period ending: 2026-09-30

Latest standalone quarter

DAR ↗

DARLING INGREDIENTS INC.

Filed: 2026-11-10
Period ending: 2026-10-03

Latest standalone quarter

PRKR ↗

PARKERVISION INC

Filed: 2026-11-10
Period ending: 2026-09-30

Latest standalone quarter

TLF ↗

TANDY LEATHER FACTORY INC

Filed: 2026-11-10
Period ending: 2026-09-30

Interpret the evidence carefully

Company figures are historical, sometimes revised and not necessarily from the same period. This tool does not include live stock prices, valuation, a prediction of future performance, or guaranteed real-time filing alerts. Use source filings to verify decisions.

Data sources and methodology →